P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias

por Richard, K, Schober, S, Rami, M, Mall, S, Merl, J, Slotta-Huspenina, J, Stevanovic, S, Busch, DH, Peschel, C, Krackhardt, AM
Publicado 2014